Ferrous sulfate in migraine headaches of childre

Phase 2

• Conditions: Migraine; Migraine.

• Registration Number: IRCT201504042639N15
• Lead Sponsor: Research Deputy of Shahid Sadoughi University of Medical Sciences , Yazd, Iran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children aged 5-15 years , Having migraine headache based on International Headache Society Criteria , Having one or more headache attack per week , Having moderate or severe headache disability , Having no iron deficiency (serum hemoglobin, iron and ferritin levels in normal limits) , Have not received iron combinations within the past two months , Not used any migraine preventive therapy
Exclusion criteria: Secondary headaches such as epilepsy or other neurologic disorders, Irregular drugs usage, Discontinuation of iron usage for more than one week

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Monthly frequency of headache. Timepoint: before and three months after treatment. Method of measurement: asking from patient.;Severity of headache. Timepoint: before and three months after treatment. Method of measurement: asking from patient.;Duration of headache. Timepoint: before and three months after treatment. Method of measurement: asking from patient.;Pediatric Migraine Disability score. Timepoint: before and three months after treatment. Method of measurement: asking from patient.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: monthly until three months after treatment. Method of measurement: clinical exam and asking from patients.